Is BSP SOLUFEN 200 mg CAPSULES* registered in South Africa?

BSP SOLUFEN 200 mg CAPSULES* is recorded with registration status “Canceled” in South Africa, registration number 27/2.7/0243, based on SAHPRA data.

What is the active ingredient in BSP SOLUFEN 200 mg CAPSULES*?

BSP SOLUFEN 200 mg CAPSULES* contains None.

Canceled South Africa · SAHPRA

BSP SOLUFEN 200 mg CAPSULES

None

27/2.7/0243

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

27/2.7/0243

Registration date

1993/01/21

Expiry date

Status

Canceled

Active ingredient

None

Dosage form

Strength

Pack size

Therapeutic class

Manufacturer / MAH

Applicant / LTR

BROVAR S & P (PTY) LTD

Country of origin

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:15:30 · updated 2026-09-16 04:00:21

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.